Company News

As an innovative R&D company specializing in genetic testing and molecular diagnostics, Tianlong has been at the forefront of driving advancements in the field. Our extensive range of products, including nucleic acid extractors, PCR thermal cyclers, Real-Time PCR systems, automatic nucleic acid workstations, and compatible kits, has revolutionized how we approach diagnostics and is transforming healthcare outcomes worldwide.

Market presence and global reach in Tianlong

At Tianlong, we take great pride in our market presence and global reach. We have achieved over 70 China National Medical Products Administration (NMPA) approvals and 120 international approvals and certifications. This recognition speaks volumes about the quality and reliability of our products. Moreover, our global market penetration spans more than 100 countries and regions, enabling us to make a significant impact on a global scale.

Our products find applications in various fields, ranging from clinical diagnostics to epidemic prevention and control, food safety, and scientific research. During major epidemics such as COVID-19, avian influenza, and Ebola outbreaks, Tianlong has played a vital role in disease detection and monitoring. By providing state-of-the-art nucleic acid testing instruments and reagents, we empower healthcare professionals and researchers to make accurate and informed decisions swiftly.

Corporate culture

At Tianlong, our corporate culture revolves around our mission to create first-class molecular diagnostic products for the betterment of human well-being. We strive to be a global leader in the field of molecular diagnostics, setting new industry standards along the way. Excellence, self-improvement, honor, and commitment are the core values that drive us forward. We believe in fostering a work environment that encourages talent based on ability, attitude, and quality, ensuring that our team remains at the forefront of innovation.

Our commitment to innovation has resulted in remarkable technical breakthroughs. We have tackled challenges related to nucleic acid extraction, rapid thermal cycling, and multiplexed nucleic acid detection, revolutionizing the field of molecular diagnostics. Our innovative technologies have made nucleic acid detection faster, more accurate, and safer, providing healthcare professionals with the confidence to make critical decisions.

The impact of our work has been recognized through numerous awards and accolades. We have received national and provincial science and technology awards that highlight our dedication to excellence and our contributions to advancing molecular diagnostics.

Conclusion

In conclusion, as Tianlong continues its journey of advancing molecular diagnostics through innovation, we invite you to explore our solutions at upcoming events like the AACC Exhibition. Our commitment to pushing the boundaries of scientific research, improving global healthcare, and shaping the future of molecular diagnostics remains unwavering. Together, let us transform the way we detect, monitor, and prevent diseases for a healthier and brighter future.